Onconetix (ONCO) Assets Average (2022 - 2026)
Onconetix (ONCO) posted quarterly Assets Average of $19.9 million for Q1 2026, down 15.33% year-over-year from $23.5 million in Q1 2025, and down 10.87% quarter-over-quarter from $22.3 million in Q4 2025.
Onconetix (ONCO) Assets Average (2022 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Assets Average for 5 consecutive years, with $19.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 15.33% year-over-year to $19.9 million; the TTM figure through Mar 2026 stood at $19.9 million (down 15.33% YoY), while the FY2025 annual figure was $26.6 million, down 54.1% from the prior year.
- Assets Average slipped to $19.9 million in Q1 2026 per ONCO's latest filing, from $22.3 million in the prior quarter.
- Across five years, Assets Average topped out at $81.3 million in Q1 2024 and bottomed at $860204.0 in Q4 2022.
- Historically, Assets Average has averaged $23.0 million across 5 years, with a median of $19.4 million in 2025.
- Annual changes were most pronounced in 2023 — Assets Average soared 5138.93% — and 2024, when it plunged 72.58%.
- Onconetix's Assets Average stood at $860204.0 in 2022, then jumped by 5138.93% to $45.1 million in 2023, then sank by 66.65% to $15.0 million in 2024, then surged by 48.41% to $22.3 million in 2025, then slipped by 10.87% to $19.9 million in 2026.
- Business Quant data shows ONCO's Assets Average at $19.9 million in Q1 2026, $22.3 million in Q4 2025, and $19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Onconetix | 1.45 Mn | -4.50 Mn | 4,303.00 | 15.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.63 Mn |
| Mar 31, 2026 | 19.88 Mn |
| Dec 31, 2025 | 22.30 Mn |
| Sep 30, 2025 | 19.40 Mn |
| Jun 30, 2025 | 18.95 Mn |
| Mar 31, 2025 | 23.48 Mn |
| Dec 31, 2024 | 15.03 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 41.02 Mn |
| Mar 31, 2024 | 81.27 Mn |
| Dec 31, 2023 | 45.07 Mn |
| Sep 30, 2023 | 16.18 Mn |
| Jun 30, 2023 | 26.12 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 860,204.00 |
| Sep 30, 2022 | 12.25 Mn |
| Jun 30, 2022 | 21.48 Mn |
| Mar 31, 2022 | 11.21 Mn |